StockNews.com initiated coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the biotechnology ...

Using NASA's TESS (Transiting Exoplanet Survey Satellite) along with observations from ground-based telescopes in Australia, ...

Aizen is using generative artificial intelligence to discover mirror peptides made entirely out of d-amino acids. Like proteins, peptides are made of amino acids, but they are shorter chains than ...

More recently, immune-modulatory approaches, including the use of T-cell checkpoint inhibitors or agents that can affect T-cell or antigen-presenting cell function, have been studied. Most ...

Origimm's expertise in the skin microbiome and antigen discovery will be central to that effort, it added. Acne affects millions of people around the world, and while it is often a problem for ...

Immatics N.V. ( (IMTX) ) has released its Q3 earnings. Here is a breakdown of the information Immatics N.V. presented to its investors.Don't ...

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with ...

TCR immunotherapy is emerging as a promising, targeted approach for treating solid tumours and other indications.

A research team behind a new study at the Hebrew University of Jerusalem has made an important breakthrough in understanding ...

AI is finding its way into every corner of biotech and pharmaceutical research, but like other industries, it’s never quite ...

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data ...

In this free webinar, learn about parameters that limit the efficacy of current chimeric antigen receptor (CAR) T-cell therapies and enable the development of CAR T-cells with enhanced performance.